Early onset of abnormal glucose tolerance in patients with cystic fibrosis: A systematic review and meta-analysis
Cystic fibrosis (CF, OMIM: 219,700) is the most prevalent autosomal recessive disease, affecting 1 in 3500 neonates [1]. Over 2000 CF-causing mutations have been discovered in the CF transmembrane conductance regulator (CFTR) gene, reducing chloride, sodium, and bicarbonate ion transport, which leads to excessive mucus production, disrupting the function of various organs (e.g. airways, gastrointestinal system), including the pancreas [2 –4].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Adrienn F. K éri, Dorina Bajzát, Zita Andrásdi, Márk Félix Juhász, Rita Nagy, Tamás Kói, Gábor Kovács, Péter Hegyi, Andrea Párniczky Tags: Review Source Type: research
More News: Chloride | Cystic Fibrosis | Gastroenterology | Genetics | Pancreas | Respiratory Medicine | Sodium